pjdog

AKS 5 year Linear Regression--stock to double by year end 2017

做多
NYSE:AKS   None
Business model has changed. No more "tons for fun". Impressive secular climb GM and EBITDA based on contract based revenue vs. volatile spot market.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。